Cogprints

Magnetic Resonance Imaging in patients with ICDs and Pacemakers

Prashant, Nair and Ariel, Roguin (2005) Magnetic Resonance Imaging in patients with ICDs and Pacemakers. [Journal (Paginated)]

Full text available as:

[img]HTML
70Kb
[img]
Preview
PDF
261Kb

Abstract

Magnetic resonance (MR) imaging has unparalleled soft-tissue imaging capabilities. The presence of devices such as pacemakers and implantable cardioverter/defibrillators (ICDs), however, is historically considered a contraindication to MR imaging. These devices are now smaller, with less magnetic material and improved electromagnetic interference protection. This review summarizes the potential hazards of the device-MR environment interaction, and presents updated information regarding in-vivo and in-vitro experiments. Recent reports on patients with implantable pacemakers and ICDs who underwent MR scan shows that under certain conditions patients with these implanted systems may benefit from this imaging modality. The data presented suggests that certain modern pacemaker and ICD systems may indeed be MR safe. This may have major clinical implications on current imaging practice.

Item Type:Journal (Paginated)
Keywords:Imaging, MRI, safety, pacemaker, ICD
Subjects:JOURNALS > Indian Pacing and Electrophysiology Journal
ID Code:4450
Deposited By:Indian Pacing and Electrophysiology, Journal
Deposited On:13 Jul 2005
Last Modified:11 Mar 2011 08:56

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1. Pinski SL, Trohman RG: Interference in implanted cardiac devices, Part II. Pacing Clin Electrophysiol 2002; 25: 1496-1509.

2. Niehaus M, Tebbenjohanns J. Electromagnetic interference in patients with implanted pacemakers or cardioverter-defibrillators. Heart 2001; 86: 246-248.

3. Hundley WG, Morgan TM, Neagle CM, et al. Magnetic resonance imaging determination of cardiac prognosis. Circulation. 2002 ;106: 2328-2333.

4. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation. 2002;106:1083-1089.

5. Kim RJ, Wu E, Rafael A, et al: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 343:1445-1453.

6. Klein C, Nekolla SG, Bengel FM, et al: Assessment of myocardial viability with contrast- enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation. 2002; 105:162-167.

7. Kalin R, Stanton MS: Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol. 2005;28:326-328.

8. Kanal E, Borgstede JP, Barkovich AJ et al: American College of Radiology White Paper on MR safety:2004 update and revisions.AJR.2004; 182:1111-1114.

9. Erlebacher JA, Cahill PT, Pannizzo F, Knowles JR. Effect of magnetic resonance imaging on DDD pacemakers. Am J Cardiol, 1986;57:437–440.

10. Hayes DL, Vlictstra RE: Pacemaker malfunction. Ann Intern Med. 1993;119:828-35

11. Pavlicek W, Geisinger M, Castle L, Borkowski GP, Meaney TF, Bream BL, Gallagher JH. The effects of NMR on patients with cardiac pacemakers. Radiology, 1983;147:149–153.

12. Fetter J, Aram G, Holmes DR, Gray JE, Hayes DL. The effects of nuclear magnetic resonance imagers on external and implantable pulse generators. Pacing Clin Electrophysiol. 1984; 7:720–727.

13. Avery JE. Loss prevention case of the month. Not my responsibility! J Tenn Med Assoc, 1988; 81:523-4.

14. Gimbel JR, Kanal E Can patients with implantable pacemakers safely undergo magnetic resonance imaging? J Am Coll Cardiol. 2004;43:1325-7.

15. Shellock FG, Crues JV III. MR Safety and the American College of Radiology White Paper. AJR 2002; 178: 1349-1352.

16. Alagona P, Toole JC, Maniscalco BS, Glover MU, Abernathy GT, Prida XA. Nuclear magnetic resonance imaging in a patient with a DDD pacemaker. Pacing Clin Electrophysiol 1989:12;619-620.

17. Inbar S, Larson J, Burt T, Mafee M, Ezri MD. Case report: Nuclear magnetic resonance imaging in a patient with a pacemaker. Am J Med Sci, 1993;305:174–175.

18. Gimbel JR, Johnson D, Levine PA, Wilkoff BL. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol. 1996; 19:913–919.

19. Fontaine JM, Mohamed FB, Gottlieb C, Callans DJ, Marchlinski FE Rapid ventricular pacing in a pacemaker patient undergoing magnetic resonance imaging. Pacing Clin Electrophysiol. 1998;21:1336-9.

20. Garcia-Bolao I, Albaladejo V, Benito A, Alegria E, Zubieta JL. Magnetic resonance imaging in a patient with a dual-chamber pacemaker. Acta Cardiologia, 1998;19:33–35.

21. Sommer T, Vahlhaus C, Lauck G, von Smekal A, Reinke M, Hofer U, Block W, Traber F, Schneider C, Gieseke J, Jung W, Schild H.MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology. 2000;215:869-79.

22. Holmes DR, Hayes DL, Gray JE, Merideth J. The effects of magnetic resonance imaging on implantable pulse generators. Pacing Clin Electrophysiol, 1986; 9:360–370.

23. Lauck G, von Smekal A, Wolke S, Seelos KC, Jung W, Manz M, Luderitz B. Effects of nuclear magnetic resonance imaging on cardiac pacemaker. Pacing Clin Electrophysiol 1995; 18:1549-55.

24. Hayes DL, Holmes DR, Gray JE. Effect of 1.5 tesla nuclear magnetic resonance imaging scanner on implated permanent pacemakers. J Am Coll Cardiol. 1987; 10:782–786.

25. Achenbach S, Moshage W, Diem B, Bieberle T, Schibgilla V, Bachmann K. Effects of magnetic resonance imaging on cardiac pacemakersand electrodes. Am Heart J 1997; 134:467–473.

26. Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA, Lardo A, Berger RD, Calkins H, Halperin HR. :Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation. 2004;110:475-82.

27. Schmiedel A, Hackenbroch M, Yang A, Nahle CP, Skowasch D, Meyer C, Schimpf R, Schild H, Sommer T. Magnetic resonance imaging of the brain in patients with cardiac pace makers. In-vitro- and in-vivo-evaluation at 1.5 Tesla. Rofo. 2005; 177:731-44.

28. Luechinger R, Zeijlemaker VA, Pedersen EM, Mortensen P, Falk E, Duru F, Candinas R, Boesiger P. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J. 2005;26:376-83.

29. Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R. Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol. 2001;24:199-205.

30. Pohost GM, Blackwell GG, Shellock FG. Safety of patients with medical devices during application of magnetic resonance methods. In Richard L. Magin, Robert P. Liburdy, and Bertil Persson editors, Biological effects and safety aspects of nuclear magnetic resonance imaging and spectroscopy, volume 649 of Annals of the New York Academy of Science, pages 302–312. New York Academy of Sciences, March 1992.

31. Vahlhaus C, Sommer T, Lewalter T, Schimpf R, Schumacher B, Jung W, Luderitz B.Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5 Tesla? Pacing Clin Electrophysiol. 2001;24:489-95.

32. Martin ET ,Coman JA, Shellock FG ,Pulling CC, Fair R ,Jenkins K: Magnetic resonance imaging and cardiac pacemaker safety at 1.5- Tesla :J Am Coll Cardiol.2004;43:1315-1324.

33. Gimbel JR, Johnson D, Levine PA, Wilkoff BL: Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol. 1996;19:913-9.

34. Peden CJ, Collins AG, Butson PC, Whitwam JG, Young IR. Induction of microcurrents in critically ill patients in magnetic resonance systems. Crit Care Med, 1993; 21:1923–1928.

35. Hartnell GG, Spence L, Hughes LA, Cohen MC, Saouaf R, Buff B. Safety of MR imaging in patients who have retained metallic materials after cardiac surgery. AJR 1997, 168:1157-1159.

36. Kanal E. Safety of MR imaging in patients with retained epicardial pacer wires (letter). AJR 1998; 170:213.

37. Gimbel JR, Trohman RL, Lindsay WC, et al. Strategies for the safe performance of magnetic resonance imaging in selected ICD patients. PACE 2002;25:618.

38. Anfinsen O, Berntsen RF, Aass H, et al. Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging. Pacing Clin Electrophysiol 2002; 25:1400-1402.

39. Fiek M, Remp T, Reithmann C, Steinbeck G. Complete loss of ICD programmability after magnetic resonance imaging. Pacing Clin Electrophysiol 2000; 27:1002-4.

40. Coman JA, Martin ET, Sandler DA, et al. Implantable cardiac defibrillator interactions with magnetic resonance imaging at 1.5 Tesla. J Am Coll Cardiol 2004;43:138A.

41. Wollmann C, Grude M, Tombach B, Kugel H, Heindel W, Breithardt G, Bocker D, Vahlhaus C. :Safe performance of Magnetic Resonance Imaging on a patient with an ICD . Pacing Clin Electrophysiol 2005; 28 :339-42.

42. Roguin A, Donahue JK, Bomma CS, Bluemke DA, Halperin HR.:Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2005;28:336-8.

.

43. Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol. 2005; 28:270-3.

44. Loewy J, Loewy A, Kendall EJ. Reconsideration of Pacemakers and MR Imaging. Radiographics 2004;24:1257-1267.

45. Schueler BA, Parrish TB, Lin J, et al. MRI compatibility and visibility assessment of implantable medical devices. J Magn Reson Imaging 1999;9:596–603.

Metadata

Repository Staff Only: item control page